KalVista Pharmaceuticals
KALV
#6279
Rank
A$1.00 B
Marketcap
$20.30
Share price
0.85%
Change (1 day)
26.26%
Change (1 year)

Earnings for KalVista Pharmaceuticals (KALV)

Earnings in 2025 (TTM): -A$0.27 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.27 Billion a decrease over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KalVista Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.27 Billion-1.15%
2024 -A$0.27 Billion43.36%
2023 -A$0.19 Billion12.87%
2022 -A$0.17 Billion20.62%
2021 -A$0.14 Billion79.87%
2020 -A$76.34 Million14.01%
2019 -A$66.96 Million98.95%
2018 -A$33.66 Million3.41%
2017 -A$32.55 Million-13.11%
2016 -A$37.46 Million1.3%
2015 -A$36.98 Million92.7%
2014 -A$19.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion-16.65%๐Ÿ‡บ๐Ÿ‡ธ USA